Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021

PharmaTech Integrates Leadership Team and Advisory Board

The Executive Advisory Board is ideally placed to provide expert insight into the critical issues and challenges facing the PharmaTech industry today. Together they bring a wealth of first-hand experience and knowledge, sharing our determination to encourage further collaboration amongst key stakeholders shaping the future of the PharmaTech industry.

We have assembled a group of renowned experts from across the sector including manufacturing, academia, technology and supply chain organisations. Kindly contact Christopher Watt or Samuel Thangiah if you would like to be considered for the PharmaTech Advisory Board.

DAVE TUDOR

Managing Director
Medicines Manufacturing Innovation Centre

CPI

CLIVE BADMAN

Executive Director

University of Strathclyde

MATTHEW DUCHARS

Chief Executive Officer

Vaccines Manufacturing and Innovation Centre

MASSIMO BRESCIANI

Industry Director, EPSRC Future Manufacturing Research Hub

CMAC

Christopher Watts

STEVE BARR

Vice President Business Development

SK biotek

JON-PAUL SHERLOCK

 Global Technology Strategy Director, MS&T

AstraZeneca

ANDREW MATTHEWS

Head of Pharma & Life Sciences

Siemens

ANDY DWYER

Ware Pilot Plant & Global Manufacturing Technology Director

GSK

Christopher Watts

JESKE SMINK

Head of Drug Substance

Silence Therapeutics

Christopher Watts

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

Christopher Watts

ROSS MACRAE

Head of Drug Product Manufacturing

Pfizer

LAURA GRIFFITHS

Innovation Lead for Medicines Manufacturing Industrial Strategy Challenge Fund

Innovate UK

Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021